Cargando…
COVID-19 vaccine immune response in patients with plasma cell dyscrasia: a systematic review
BACKGROUND: Patients with plasma cell dyscrasia are at a higher risk of developing a severe Coronavirus-2019 (COVID-19) infection. Here we present a systematic review of clinical studies focusing on the immune response to the COVID-19 vaccination in patients with plasma cell dyscrasia. OBJECTIVES: T...
Autores principales: | Faizan, Unaiza, Nair, Lakshmi G., Bou Zerdan, Maroun, Jaberi-Douraki, Majid, Anwer, Faiz, Raza, Shahzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461737/ https://www.ncbi.nlm.nih.gov/pubmed/37645011 http://dx.doi.org/10.1177/25151355231190497 |
Ejemplares similares
-
COVID-19 vaccine immune response and plasma cell dyscrasia
por: Kleebayoon, Amnuay, et al.
Publicado: (2023) -
EFFICACY AND SAFETY OF THERAPEUTIC VERSUS PROPHYLACTIC ANTICOAGULATION IN PATIENTS WITH COVID-19 INFECTION: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS
por: FAIZAN, UNAIZA, et al.
Publicado: (2022) -
Systemic AL amyloidosis: current approach and future direction
por: Bou Zerdan, Maroun, et al.
Publicado: (2023) -
Addendum: Systemic AL amyloidosis: current approach and future direction
por: Bou Zerdan, Maroun, et al.
Publicado: (2023) -
Telomerase activity in plasma cell dyscrasias
por: Xu, D, et al.
Publicado: (2001)